The impact of a human IGF-II analog ([Leu27]IGF-II) on fetal growth in a mouse model of fetal growth restriction

American Journal of Physiology - Endocrinology and Metabolism

Volumn 310, Issue 1, 2015, Pages E24-E31

  Charnock, Jayne C ^a,b   Dilworth, Mark R ^a,b   Aplin, John D ^a,b   Sibley, Colin P ^a,b   Westwood, Melissa ^a,b   Crocker, Ian P ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Endothelial nitric oxide synthase knockout; Fetal growth restriction; Insulin like growth factor; Leu27 insulin like growth factor II

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; RECOMBINANT PROTEIN; SOMATOMEDIN B RECEPTOR; UNCLASSIFIED DRUG; [27 LEUCINE] SOMATOMEDIN B; INSULIN-LIKE GROWTH FACTOR II, LEU(27)-; NOS3 PROTEIN, MOUSE; SOMATOMEDIN B;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCULATION; CONTROLLED STUDY; FETUS; FETUS GROWTH; FETUS WEIGHT; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; LITTER SIZE; MOUSE; MOUSE MODEL; NONHUMAN; OSMOTIC PUMP; PLACENTA WEIGHT; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; FEMALE; FETAL GROWTH RETARDATION; FETUS DEVELOPMENT; GENETICS; HUMAN; KNOCKOUT MOUSE; MAMMALIAN EMBRYO; PATHOLOGY; PREGNANCY;

ANIMALS; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; PREGNANCY; RECOMBINANT PROTEINS;

EID: 84949545651     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00379.2015     Document Type: Article

References (45)

1. Barker DJ. The fetal and infant origins of adult disease. BMJ 301: 1111, 1990.
2. Barker DJ. Fetal origins of coronary heart disease. Br Heart J 69: 195–196, 1993.
3. Barker DJ, Fall CH. Fetal and infant origins of cardiovascular disease. Arch Dis Child 68: 797–799, 1993.
4. Barry JS, Anthony RV. The pregnant sheep as a model for human pregnancy. Theriogenology 69: 55–67, 2008.
5. Bond H, Dilworth MR, Baker B, Cowley E, Requena Jimenez A, Boyd RD, Husain SM, Ward BS, Sibley CP, Glazier JD. Increased maternofetal calcium flux in parathyroid hormone-related protein-null mice. J Physiol 586: 2015–2025, 2008.
6. Carter AM. Current topic: restriction of placental and fetal growth in the guinea-pig. Placenta 14: 125–135, 1993.
7. Chen CP, Bajoria R, Aplin JD. Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms. Am J Obstet Gynecol 187: 764–769, 2002.
8. Coan PM, Angiolini E, Sandovici I, Burton GJ, Constancia M, Fowden AL. Adaptations in placental nutrient transfer capacity to meet fetal growth demands depend on placental size in mice. J Physiol 586: 4567–4576, 2008.
9. Coan PM, Fowden AL, Constancia M, Ferguson-Smith AC, Burton GJ, Sibley CP. Disproportional effects of Igf2 knockout on placental morphology and diffusional exchange characteristics in the mouse. J Physiol 586: 5023–5032, 2008.
10. Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417: 945–948, 2002.
11. Dilworth MR, Kusinski LC, Baker BC, Renshall LJ, Baker PN, Greenwood SL, Wareing M, Sibley CP. Crossing mice deficient in eNOS with placental-specific Igf2 knockout mice: a new model of fetal growth restriction. Placenta 33: 1052–1054, 2012.
12. Dilworth MR, Kusinski LC, Baker BC, Renshall LJ, Greenwood SL, Sibley CP, Wareing M. Defining fetal growth restriction in mice: A standardized and clinically relevant approach. Placenta 32: 914–916, 2011.
13. Dilworth MR, Kusinski LC, Cowley E, Ward BS, Husain SM, Constancia M, Sibley CP, Glazier JD. Placental-specific Igf2 knockout mice exhibit hypocalcemia and adaptive changes in placental calcium transport. Proc Natl Acad Sci USA 107: 3894–3899, 2010.
14. El-Shewy HM, Johnson KR, Lee MH, Jaffa AA, Obeid LM, Luttrell LM. Insulin-like growth factors mediate heterotrimeric G protein-dependent ERK1/2 activation by transactivating sphingosine 1-phosphate receptors. J Biol Chem 281: 31399–31407, 2006.
15. El-Shewy HM, Lee MH, Obeid LM, Jaffa AA, Luttrell LM. The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells. J Biol Chem 282: 26150–26157, 2007.
16. Forbes K, Westwood M. The IGF axis and placental function. a mini review. Horm Res 69: 129–137, 2008.
17. Forbes K, Westwood M, Baker PN, Aplin JD. Insulin-like growth factor I and II regulate the life cycle of trophoblast in the developing human placenta. Am J Physiol Cell Physiol 294: C1313–C1322, 2008.
18. Gibson JM, Aplin JD, White A, Westwood M. Regulation of IGF bioavailability in pregnancy. Mol Hum Reprod 7: 79–87, 2001.
19. Han VK, Carter AM. Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta 21: 289–305, 2000.
20. Harris LK, Crocker IP, Baker PN, Aplin JD, Westwood M. IGF2 actions on trophoblast in human placenta are regulated by the insulin-like growth factor 2 receptor, which can function as both a signaling and clearance receptor. Biol Reprod 84: 440–446, 2011.
21. Harris LK, Westwood M. Biology and significance of signalling pathways activated by IGF-II. Growth Factors 30: 1–12, 2012.
22. Heazell AE, Crocker IP. Live and let die - regulation of villous trophoblast apoptosis in normal and abnormal pregnancies. Placenta 29: 772–783, 2008.
23. Hefler LA, Reyes CA, O’Brien WE, Gregg AR. Perinatal development of endothelial nitric oxide synthase-deficient mice. Biol Reprod 64: 666–673, 2001.
24. Herr F, Liang OD, Herrero J, Lang U, Preissner KT, Han VK, Zygmunt M. Possible angiogenic roles of insulin-like growth factor II and its receptors in uterine vascular adaptation to pregnancy. J Clin Endocrinol Metab 88: 4811–4817, 2003.
25. Junaid TO, Brownbill P, Chalmers N, Johnstone ED, Aplin JD. Fetoplacental vascular alterations associated with fetal growth restriction. Placenta 35: 808–815, 2014.
26. Kniss DA, Shubert PJ, Zimmerman PD, Landon MB, Gabbe SG. Insulinlike growth factors. Their regulation of glucose and amino acid transport in placental trophoblasts isolated from first-trimester chorionic villi. J Reprod Med 39: 249–256, 1994.
27. Kusinski LC, Stanley JL, Dilworth MR, Hirt CJ, Andersson IJ, Renshall LJ, Baker BC, Baker PN, Sibley CP, Wareing M, Glazier JD. eNOS knockout mouse as a model of fetal growth restriction with an impaired uterine artery function and placental transport phenotype. Am J Physiol Regul Integr Comp Physiol 303: R86–R93, 2012.
28. Lafeber HN, Rolph TP, Jones CT. Studies on the growth of the fetal guinea pig. The effects of ligation of the uterine artery on organ growth and development. J Dev Physiol 6: 441–459, 1984.
29. Lau MM, Stewart CE, Liu Z, Bhatt H, Rotwein P, Stewart CL. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 8: 2953–2963, 1994.
30. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75: 59–72, 1993.
31. Mayhew TM, Ohadike C, Baker PN, Crocker IP, Mitchell C, Ong SS. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta 24: 219–226, 2003.
32. McKinnon T, Chakraborty C, Gleeson LM, Chidiac P, Lala PK. Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab 86: 3665–3674, 2001.
33. Miller BS, Yee D. Type I insulin-like growth factor receptor as a therapeutic target in cancer. Cancer Res 65: 10123–10127, 2005.
34. Nayak NR, Giudice LC. Comparative biology of the IGF system in endometrium, decidua, and placenta, and clinical implications for foetal growth and implantation disorders. Placenta 24: 281–296, 2003.
35. Osmond C, Kajantie E, Forsen TJ, Eriksson JG, Barker DJ. Infant growth and stroke in adult life: the Helsinki birth cohort study. Stroke 38: 264–270, 2007.
36. Regnault TR, Marconi AM, Smith CH, Glazier JD, Novak DA, Sibley CP, Jansson T. Placental amino acid transport systems and fetal growth restriction—a workshop report. Placenta 26, Suppl A: S76–S80, 2005.
37. Resnik R. Intrauterine growth restriction. Obstet Gynecol 99: 490–496, 2002.
38. Sferruzzi-Perri AN, Owens JA, Pringle KG, Robinson JS, Roberts CT. Maternal insulin-like growth factors-I and -II act via different pathways to promote fetal growth. Endocrinology 147: 3344–3355, 2006.
39. Sferruzzi-Perri AN, Owens JA, Standen P, Roberts CT. Maternal insulin-like growth factor-II promotes placental functional development via the type 2 IGF receptor in the guinea pig. Placenta 29: 347–355, 2008.
40. Sferruzzi-Perri AN, Owens JA, Standen P, Taylor RL, Heinemann GK, Robinson JS, Roberts CT. Early treatment of the pregnant guinea pig with IGFs promotes placental transport and nutrient partitioning near term. Am J Physiol Endocrinol Metab 292: E668–E676, 2007.
41. Sibley CP, Turner MA, Cetin I, Ayuk P, Boyd CA, D’Souza SW, Glazier JD, Greenwood SL, Jansson T, Powell T. Placental phenotypes of intrauterine growth. Pediatr Res 58: 827–832, 2005.
42. Siler-Khodr TM, Forman J, Sorem KA. Dose-related effect of IGF-I on placental prostanoid release. Prostaglandins 49: 1–14, 1995.
43. Wigglesworth JS. Fetal growth retardation. Animal model: uterine vessel ligation in the pregnant rat. Am J Pathol 77: 347–350, 1974.
44. Wylie AA, Pulford DJ, McVie-Wylie AJ, Waterland RA, Evans HK, Chen YT, Nolan CM, Orton TC, Jirtle RL. Tissue-specific inactivation of murine M6P/IGF2R. Am J Pathol 162: 321–328, 2003.
45. Zhou J, Bondy C. Insulin-like growth factor-II and its binding proteins in placental development. Endocrinology 131: 1230–1240, 1992.